Mankind Pharma Ltd (MANKIND) — Capital Reinvestment Ratio
Mankind Pharma Ltd (MANKIND) has a Capital Reinvestment Ratio of 0.17x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs16.37 Billion) in capital expenditures (Rs2.71 Billion). Check tangible equity quality of Mankind Pharma Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Mankind Pharma Ltd Capital Reinvestment Ratio (2019–2026)
This chart tracks Mankind Pharma Ltd's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see MANKIND cash flow conversion.
Annual Capital Reinvestment Ratio for Mankind Pharma Ltd (2019–2026)
Year-by-year Capital Reinvestment Ratio for Mankind Pharma Ltd from 2019 to 2026. See MANKIND free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.25x | Rs25.16 Billion | Rs6.26 Billion | ▲ +30.3% |
| 2025 | 0.19x | Rs24.13 Billion | Rs4.61 Billion | ▲ +7.5% |
| 2024 | 0.18x | Rs21.52 Billion | Rs3.82 Billion | ▼ -61.3% |
| 2023 | 0.46x | Rs18.13 Billion | Rs8.32 Billion | ▼ -82.0% |
| 2022 | 2.55x | Rs9.20 Billion | Rs23.46 Billion | ▲ +828.6% |
| 2021 | 0.27x | Rs11.37 Billion | Rs3.12 Billion | ▲ +28.9% |
| 2020 | 0.21x | Rs10.70 Billion | Rs2.28 Billion | ▼ -57.0% |
| 2019 | 0.50x | Rs6.00 Billion | Rs2.98 Billion | — |